TBD

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$7,000,000 to $13,000,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Department of Health and Human Services Indian Health Service is forecasting a contract opportunity for flu-related biological product manufacturing, with a NAICS code of 325414. The estimated solicitation release date is April 1, 2025, with an anticipated contract award date of June 1, 2025. The contract appears to be focused on flu vaccine or related biological product procurement without any specific set-aside restrictions.

The current incumbent contractors include Seqirus, Sanofi, and GSK, suggesting this is a potential re-compete or expansion of existing biological product manufacturing services. Key points of contact are Aaron Cardenaz (Program Manager) and Sean Long (Contracting Officer), both from IHS, who can be reached at their respective IHS email addresses and phone numbers. While specific award values are not disclosed in the forecast, interested vendors in the biological product manufacturing sector should monitor this opportunity, particularly those with experience in vaccine or flu-related product development and manufacturing.

Forecast text

Flu

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast